Journal
PHARMACEUTICS
Volume 14, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics14020426
Keywords
cancer; lipid metabolism; choline kinase inhibitors; choline uptake
Categories
Funding
- Ministerio de Ciencia e Innovacion [PID2019-109294RB-100]
- Andalusian regional government [CTS-236, B-CTS-216-UGR20]
- Ministerio de Ciencia, Innovacion y Universidades (Spain) [PRE2018-085440]
- European Regional Development Fund (ERDF) project BioDrug [1.1.1.5/19/A/004]
- Latvian Council of Science [lzp-2020/2-0013]
Ask authors/readers for more resources
The overexpression of Choline Kinase alpha 1 (ChoK alpha 1) has been associated with cell proliferation, oncogenic transformation, and carcinogenesis, making it a potential target in cancer therapy. Additionally, the choline transporter CTL1 is highly expressed in tumor cell lines. Inhibition of both choline uptake and ChoK alpha 1 activity has been shown to correlate with reduced cell proliferation in cancer cell lines, suggesting both proteins as potential targets for cancer therapy.
A large number of different types of cancer have been shown to be associated with an abnormal metabolism of phosphatidylcholine (PC), the main component of eukaryotic cell membranes. Indeed, the overexpression of choline kinase alpha 1 (ChoK alpha 1), the enzyme that catalyses the bioconversion of choline to phosphocholine (PCho), has been found to associate with cell proliferation, oncogenic transformation and carcinogenesis. Hence, ChoK alpha 1 has been described as a possible cancer therapeutic target. Moreover, the choline transporter CTL1 has been shown to be highly expressed in several tumour cell lines. In the present work, we evaluate the antiproliferative effect of PL48, a rationally designed inhibitor of ChoK alpha 1, in MCF7 and HepG2 cell lines. In addition, we illustrate that the predominant mechanism of cellular choline uptake in these cells is mediated by the CTL1 choline transporter. A possible correlation between the inhibition of both choline uptake and ChoK alpha 1 activity and cell proliferation in cancer cell lines is also highlighted. We conclude that the efficacy of this inhibitor on cell proliferation in both cell lines is closely correlated with its capability to block choline uptake and ChoK alpha 1 activity, making both proteins potential targets in cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available